Pall Corporation

Pall can provide fully integrated bioprocessing solutions for gene therapy, from discovery through to commercialization; from upstream through to final filling; from initial design through to implementation.  With a range of solutions covering multiple virus types, and with production in either adherent or suspension processes, our extensive single-use portfolio can offer you the complete solution you need.